1. Sancuso [package insert], Bedminster, NJ, Kyowa Kirin, Inc.
  2. Schulmeister L. Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 2009;13:711- 714.
  3. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm. 1999;56:729-764.
  4. American Cancer Society. Caring for the patient with cancer at home: a guide for patients and families. http://www.cancer.org/acs/groups/cid/documents/ webcontent/002818-pdf.pdf. Accessed October 2017.
  5. Cancer.net. Information from the American Society of Clinical Oncology. http://www.cancer.net/all-about-cancer/treating-cancer/managing-side-effects/difficulty-swallowing-or-dysphagia. Accessed October 2017.
  6. National Institutes of Health. National Institutes of Health Web site: What causes dysphagia? http://www.nidcd.nih.gov/health/voice/pages/dysph.aspx#5. Accessed October 2017.
  7. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: Quality of life issues. Cancer. 2002;94:1131-1141.
  8. Parkman H, Hasler W, Fisher R. The American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-1622.
  9. Boccia RV, Gordan LN, Clark G, et al. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Support Care Cancer. 2011;19:1609- 1617.